Search research articles
Contact Us
Filters
Showing results (1-10 of 63) with videos related to
Page
of 7
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 13, 2018
Get Outta Here! Addition of Mobilizing Agents to Conditioning Regimen Improves Donor Engraftment after Allogeneic Hematopoietic Stem Cell Transplantation for Wiskott-Aldrich Syndrome
Michael P Rettig
Blood
|
December 8, 2018
CiTE antibody for AML
Michael P Rettig, John F DiPersio
Frontiers in Oncology
|
October 5, 2020
Targeting CXCR4 in AML and ALL
Daniel Cancilla, Michael P Rettig, John F DiPersio
F1000Research
|
February 7, 2020
Mobilized peripheral blood: an updated perspective
Darja Karpova, Michael P Rettig, John F DiPersio
Expert Opinion on Biological Therapy
|
October 14, 2008
Plerixafor, a CXCR4 antagonist for the mobilization of hematopoietic stem cells
Geoffrey L Uy, Michael P Rettig, Amanda F Cashen
Therapeutic Advances in Hematology
|
May 30, 2023
Innovations in hematopoietic stem-cell mobilization: a review of the novel CXCR4 inhibitor motixafortide
Zachary D Crees, Michael P Rettig, John F DiPersio
Biomolecules
|
August 29, 2024
Development of VLA4 and CXCR4 Antagonists for the Mobilization of Hematopoietic Stem and Progenitor Cells
Peter G Ruminski, Michael P Rettig, John F DiPersio
Methods in Enzymology
|
May 19, 2009
CXCR4 and mobilization of hematopoietic precursors
Michael P Rettig, Pablo Ramirez, Bruno Nervi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 12, 2021
Biology of Disease Relapse in Myeloid Disease: Implication for Strategies to Prevent and Treat Disease Relapse After Stem-Cell Transplantation
Joseph C Rimando, Matthew J Christopher, Michael P Rettig, et al.
Biochemistry
|
October 9, 2002
Protein kinase C activation induces phosphatidylserine exposure on red blood cells
Kitty de Jong, Michael P Rettig, Philip S Low, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 63) with videos related to
Sort By:
Page
of 7
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 13, 2018
Get Outta Here! Addition of Mobilizing Agents to Conditioning Regimen Improves Donor Engraftment after Allogeneic Hematopoietic Stem Cell Transplantation for Wiskott-Aldrich Syndrome
Michael P Rettig
Blood
|
December 8, 2018
CiTE antibody for AML
Michael P Rettig, John F DiPersio
Frontiers in Oncology
|
October 5, 2020
Targeting CXCR4 in AML and ALL
Daniel Cancilla, Michael P Rettig, John F DiPersio
F1000Research
|
February 7, 2020
Mobilized peripheral blood: an updated perspective
Darja Karpova, Michael P Rettig, John F DiPersio
Expert Opinion on Biological Therapy
|
October 14, 2008
Plerixafor, a CXCR4 antagonist for the mobilization of hematopoietic stem cells
Geoffrey L Uy, Michael P Rettig, Amanda F Cashen
Therapeutic Advances in Hematology
|
May 30, 2023
Innovations in hematopoietic stem-cell mobilization: a review of the novel CXCR4 inhibitor motixafortide
Zachary D Crees, Michael P Rettig, John F DiPersio
Biomolecules
|
August 29, 2024
Development of VLA4 and CXCR4 Antagonists for the Mobilization of Hematopoietic Stem and Progenitor Cells
Peter G Ruminski, Michael P Rettig, John F DiPersio
Methods in Enzymology
|
May 19, 2009
CXCR4 and mobilization of hematopoietic precursors
Michael P Rettig, Pablo Ramirez, Bruno Nervi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 12, 2021
Biology of Disease Relapse in Myeloid Disease: Implication for Strategies to Prevent and Treat Disease Relapse After Stem-Cell Transplantation
Joseph C Rimando, Matthew J Christopher, Michael P Rettig, et al.
Biochemistry
|
October 9, 2002
Protein kinase C activation induces phosphatidylserine exposure on red blood cells
Kitty de Jong, Michael P Rettig, Philip S Low, et al.
Page
of 7